drugset / Trial / NCT04601974
Lentiviral Gene Therapy for Epilepsy
Phase 1/2
Not yet recruiting
10 enrolled
University College, London
Medical Research Council · collab
NaSingle-groupOpen-labelTreatment
Summary
This is a phase I/IIa clinical trial investigating the safety of a lentiviral epilepsy gene therapy using an engineered potassium channel in patients with refractory epilepsy.
Timeline
- Start
- 2024-09
- Primary completion
- 2028-09
- Completion
- 2032-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | lentiviral gene therapy | Unknown | — | Other |